Review: Amyloidogenesis - Unquestioned answers and unanswered questions

Journal of Structural Biology

Volumn 130, Issue 2-3, 2000, Pages 99-108

  Kisilevsky, Robert ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

AA; Amylin; Amyloid; A ; Collagen IV; Common components; Fibril formation; Genetics; Heparan sulfate; IAPP; Kinetics; Laminin; Nucleation; Review; Transthyretin

Indexed keywords

AMYLIN; AMYLOID; COLLAGEN TYPE 4; LAMININ; PREALBUMIN;

AMYLOIDOSIS; GENETIC RISK; HUMAN; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN SECONDARY STRUCTURE; REVIEW;

EID: 0033865052     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsbi.2000.4222     Document Type: Review

References (135)

1. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis
2. Characterization of high affinity binding between laminin and the acute-phase protein, serum amyloid A
3. The heparin/heparan sulfate-binding site on apo-serum amyloid A: Implications for the therapeutic intervention of amyloidosis
4. Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation
5. Transformation from SAA2-fibrils to AA-fibrils in amyloid fibrillogenesis: In vivo observations in murine spleen using anti-SAA and anti-AA antibodies
6. Perlecan is essential for cartilage and cephalic development
7. The structural basis of pancreatic amyloid formation - Isotope-edited spectroscopy in the solid state
8. Interspecies sequence variations affect the kinetics and thermodynamics of amyloid formation - Peptide models of pancreatic amyloid
9. Biological characterizations of amyloid enhancing factor
10. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
11. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease - Analysis of circular dichroism spectra
12. Prealbumin and retinol binding protein serum concentrations in the Indiana type heredity amyloidosis
13. Transthyretin amyloidosis
14. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation
15. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene
16. Apolipoprotein E carboxy-terminal fragments are complexed to amyloids A and L - Implications for amyloidogenesis and Alzheimer's disease
17. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy
18. In situ characterization of β-amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared microspectroscopy
19. Identification of heparin-binding domains in the amyloid precursor protein of Alzheimer's disease by deletion mutagenesis and peptide mapping
20. The constitution and genesis of amyloid
21. High resolution ultrastructure, immunology, and biochemistry of amyloid
22. Electron microscopic observations on fibrous component in amyloid of diverse origins
23. Structural prerequisites for serum amyloid A fibril formation
24. Resolution of heart failure in patients with AL amyloidosis
25. X-ray diffraction studies on amyloid filaments
26. Prionics or the kinetic basis of prion diseases
27. Apolipoprotein E and apolipoprotein A-I knock-out mice readily develop amyloid A protein amyloidosis
28. Primary structure of duck amyloid protein A: The form deposited in tissues may be identical to its serum precursor
29. Liver transplant halts the progress of familial amyloidotic polyneuropathy
30. Stereochemical specificity of Alzheimer's disease β-peptide assembly
31. Comparative analysis of human and Dutch-type Alzheimer beta-amyloid peptides by infrared spectroscopy and circular dichroism
32. NF-kappa B immunoreactivity is observed in association with βA4 diffuse plaques in patients with Alzheimer's disease
33. Potential role of apolipoprotein-E in fibrillogenesis
34. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice
35. Advances in ultrarapid freezing for the preservation of cellular ultrastructure
36. The relationship of the two fiber types characteristic of human amyloid deposits
37. Amyloid, amyloidosis, and amyloidogenesis
38. Amyloid fibril proteins: Proof of homology with immunoglobulin light chains by sequence analysis
39. Watching amyloid fibrils grow by time-lapse atomic force microscopy
40. Complete clinical remission and subsequent relapse of bronchiectasis-related (AA) amyloid induced nephrotic syndrome
41. An electron-microscopic study of amyloldosis from different species
42. Location of beta-sheet-forming sequences in amyloid proteins by FTIR
43. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy
44. Freeze-substitution
45. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo
46. Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis
47. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression
48. Geographical distribution of TTR met(30) carriers in northern Sweden: Discrepancy between carrier frequency and prevalence rate
49. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis
50. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30)
51. Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice
52. A high resolution ultrastructural study of experimental murine AA amyloid
53. Basement membranes, microfibrils and β amyloid fibrillogenesis in Alzheimer's disease: High resolution ultrastructural findings
54. Ultrastructural organization of hemodialysis-associated beta(2)-microglobulin amyloid fibrils
55. Ultrastructure of familial amyloid polyneuropathy amyloid fibrils: Examination with high-resolution electron microscopy
56. A high resolution ultrastructural comparison of isolated and in situ murine AA amyloid fibrils
57. Coexistence of AL and Aβ2M amyloid in tissues of a patient with myeloma on hemodialysis
58. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans
59. Amyloid fibril formation requires a chemically discriminating nucleation event - Studies of an amyloidogenic sequence from the bacterial protein OsmB
60. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils
61. Retinol-binding protein: The Transport protein for vitamin A in human plasma
62. The amino acid sequence of human plasma prealbumin
63. Amyloid fibril formation and protein misassembly: A structural quest for insights into amyloid and prion diseases
64. A chemical approach to elucidate the mechanism of transthyretin and β-protein amyloid fibril formation
65. Association of apolipoprotein E with murine amyloid A protein amyloid
66. Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice
67. The kinetics of amyloid deposition: I. The effect of amyloid enhancing factor and splenectomy
68. Kinetics of amyloid deposition. II. The effects of dimethylsulfoxide and colchicine therapy
69. Proteoglycans and amyloid fibrillogenesis
70. Aβ amyloidogenesis: Unique or variation on a systemic theme?
71. Does amyloid enhancing factor (AEF) exist? Is AEF a single biological entity?
72. New clothes for amyloid enhancing factor (AEF): Silk as AEF
73. During AA amyloidogenesis is proteolytic attack on serum amyloid A a pre- or post-fibrillogenic event?
74. In situ atomic force microscopy study of Alzheimer's β-amyloid peptide on different substrates: New insights into mechanism of β-sheet formation
75. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid
76. In pursuit of the molecular structure of amyloid plaque - New technology provides unexpected and critical information
77. A 25,000 molecular weight protein constituent of human amyloid fibrils related to amyloid protein AA
78. Fractionation of primary amyloid fibrils. Characterization and chemical interaction of the subunits
79. Amyloid β protein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles
80. Kinetic theory of fibrillogenesis of amyloid β-protein
81. Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease
82. Kinetics and mechanism of amyloid formation by the prion protein H1 peptide as determined by time-dependent ESR
83. Co-deposition of basement membrane components during the induction of murine splenic AA amyloid
84. Circular dichroism and fluorescence studies on two murine serum amyloid A proteins
85. A sulfated proteoglycan aggregation factor mediates amyloid-β peptide fibril formation and neurotoxicity
86. Spontaneous remissions of nephrotic syndrome in renal amyloidosis
87. Ultrastructure of perivascular amyloid fibrils in Alzheimer's disease
88. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome
89. Structure of a complex of two plasma proteins: Transthyretin and retinol-binding protein
90. Identification and regulation of the high affinity binding site of the Alzheimer's disease amyloid protein precursor (APP) to glycosaminoglycans
91. Familial carpal tunnel syndrome due to amyloidogenic transthyretin his 114 variant
92. Two transthyretin variants, Ser 6 and Met 111, in a Danish kindred with familial amyloid cardiomyopathy: Implications for serum TTR and thyroxine hormone levels
93. Verification of the transthyretin Met-111 mutation in familial amyloid cardiomyopathy of Danish origin by DNA sequencing
94. Serum amyloid A and beta-2-microglobulin interactions with glycosaminoglycans: Upper limits of their dissociation constants, VIII International symposium on amyloidosis
95. Clusterin (apoJ) alters the aggregation of amyloid β-peptide (Aβ (1-42)) and forms slowly sedimenting Aβ complexes that cause oxidative stress
96. Secondary structure of endocrine amyloid: Infrared spectroscopy of medullary carcinoma of the thyroid
97. Association between vascular basement membrane components and the lesions of Alzheimer's disease
98. Microangiopathy, the vascular basement membrane and Alzheimers disease - A review
99. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimers disease
100. Vascular basement membrane components and the lesions of Alzheimer's disease: Light and electron microscopic analyses
101. The characterization of soluble amyloid prepared in water
102. Genetics of prions
103. On the binding of Congo red by amyloid
104. Proteins associated with the thyroid hormones
105. Several different types of amyloid in a 93-year-old woman patient - Case history up to and including autopsy report
106. Transthyretin mutations in health and disease
107. Molecular genetics of familial amyloidotic polyneuropathy
108. The evolution of gene expression, structure and function of transthyretin
109. Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support
110. High resolution electron microscopic analysis of the amyloid fibril
111. Serum prealbumin and retinol-binding protein concentrations in Japanese-type familial amyloid polyneutropathy
112. Lowered prealbumin levels in patients with familial amyloid polyneuropathy (FAP) and their non-affected but at risk relatively
113. Specific proteoglycans as potential causative agents and relevant targets for therapeutic intervention in Alzheimer's disease and other amyloidoses
114. Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Quantitative and qualitative analysis
115. Remission of nephrotic syndrome in amyloidosis associated with a hypernephroma
116. Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits
117. Structural and kinetic features of amyloid β-protein fibrillogenesis
118. Ultrastructural studies in Alzheimer's presenile dementia
119. Amyloid polyneuropathy in two German-American families: A new transthyretin variant (Val 107)
120. Clinical remission after syngeneic bone marrow transplantation in a patient with AL amyloidosis
121. Fluorescent stains with special reference to amyloid and connective tissue
122. Meningo-cerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD18G)
123. Zur cellulosefrage
124. The resolution of amyloid substance
125. Massive vascular AA-amyloidosis - A histologically and biochemically distinctive subtype of reactive systemic amyloidosis
126. Amyloid fibril protein AA: Characterization of uncommon subspecies from a patient with rheumatoid arthritis
127. Classification of amyloid fibril proteins and their precursors: An ongoing discussion
128. Serum prealbumin and retinol-binding in the prealbumin-related senile and familial forms of systemic amyloidosis
129. Experimental AA amyloidogenesis is associated with differential expression of extracellular matrix genes
130. Direct evidence for SAA deposition in tissues during murine amyloidogenesis
131. A monoclonal antibody recognizing apolipoprotein E peptides in systemic amyloid deposits
132. Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type-II diabetes mellitus